Literature DB >> 11807821

Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells.

Jorge N Artaza1, Shalender Bhasin, Con Mallidis, Wayne Taylor, Kun Ma, Nestor F Gonzalez-Cadavid.   

Abstract

Myostatin is a negative regulator of skeletal muscle growth. We have previously reported that recombinant myostatin protein inhibits DNA and protein synthesis in C2C12 cells. Our objective was to assess if C2C12 cells express myostatin, determine its sub-cellular localization and the developmental stage of C2C12 cells in which myostatin mRNA and protein are expressed. To study the endogenous expression of myostatin, C2C12 myoblasts were allowed to progress to myotubes, and changes in the levels of endogenous myostatin mRNA expression were determined by RT-PCR. The myostatin protein and the two major myosin heavy chain (MHC) isoforms (MHC-I and -II) were determined by Western blot. Confirmation of the relative MHC expression patterns was obtained by a modified polyacrylamide gel electropheretic (PAGE) procedure. Imunofluorescence staining was employed to localize the site of myostatin expression and the relative distribution of the MHC isoforms. Co-expression of these proteins was studied using a dual staining approach. Expression of myostatin mRNA was found in myotubes but not in myoblasts. Myostatin protein was seen in most but not all, of the nuclei of polynucleated fibers expressing MHC-II, and myostatin was detected in the cytoplasm of myotube. The localization of myostatin protein in myotube nuclei was confirmed by Western blot of isolated nuclear and cytoplasmic fractions. Incubation of C2C12 myotubes with graded doses of dexamethasone dose-dependently increased the intensity of nuclear myostatin immunostaining and also resulted in the appearance of cytoplasmic expression. In conclusion, myostatin was expressed mostly in C2C12 myotubes nuclei expressing MHC-II. Its predominant nuclear localization suggests that it may play a role in transcriptional regulation. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807821     DOI: 10.1002/jcp.10044

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  34 in total

1.  Muscle IGF-I Ea, MGF, and myostatin mRNA expressions after compensatory overload in hypophysectomized rats.

Authors:  Akihiko Yamaguchi; Takahiko Fujikawa; Seita Shimada; Isao Kanbayashi; Masaru Tateoka; Hideaki Soya; Hidekatsu Takeda; Isao Morita; Kunio Matsubara; Toshihiro Hirai
Journal:  Pflugers Arch       Date:  2006-08-29       Impact factor: 3.657

2.  CREB, NF-Y and MEIS1 conserved binding sites are essential to balance Myostatin promoter/enhancer activity during early myogenesis.

Authors:  Carla Vermeulen Carvalho Grade; Carolina Stefano Mantovani; Marina Alves Fontoura; Faisal Yusuf; Beate Brand-Saberi; Lúcia Elvira Alvares
Journal:  Mol Biol Rep       Date:  2017-09-27       Impact factor: 2.316

3.  Sodium arsenite represses the expression of myogenin in C2C12 mouse myoblast cells through histone modifications and altered expression of Ezh2, Glp, and Igf-1.

Authors:  Gia-Ming Hong; Lisa J Bain
Journal:  Toxicol Appl Pharmacol       Date:  2012-03-09       Impact factor: 4.219

4.  AMP-activated protein kinase stimulates myostatin expression in C2C12 cells.

Authors:  Arun K Das; Qi-Yuan Yang; Xing Fu; Jun-Fang Liang; Marcio S Duarte; Mei-Jun Zhu; Grant D Trobridge; Min Du
Journal:  Biochem Biophys Res Commun       Date:  2012-09-06       Impact factor: 3.575

5.  1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells.

Authors:  Leah A Garcia; Keisha K King; Monica G Ferrini; Keith C Norris; Jorge N Artaza
Journal:  Endocrinology       Date:  2011-06-14       Impact factor: 4.736

6.  Non-equivalence of nuclear import among nuclei in multinucleated skeletal muscle cells.

Authors:  Alicia A Cutler; Jennifer B Jackson; Anita H Corbett; Grace K Pavlath
Journal:  J Cell Sci       Date:  2018-02-05       Impact factor: 5.285

7.  Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors.

Authors:  Rajan Singh; Jorge N Artaza; Wayne E Taylor; Melissa Braga; Xin Yuan; Nestor F Gonzalez-Cadavid; Shalender Bhasin
Journal:  Endocrinology       Date:  2005-10-06       Impact factor: 4.736

Review 8.  Skeletal muscle atrophy: disease-induced mechanisms may mask disuse atrophy.

Authors:  C J Malavaki; G K Sakkas; G I Mitrou; A Kalyva; I Stefanidis; K H Myburgh; C Karatzaferi
Journal:  J Muscle Res Cell Motil       Date:  2016-01-04       Impact factor: 2.698

9.  Embryonic and tissue-specific regulation of myostatin-1 and -2 gene expression in zebrafish.

Authors:  Deri L I Helterline; Dilip Garikipati; Deborah L Stenkamp; Buel D Rodgers
Journal:  Gen Comp Endocrinol       Date:  2007-01-04       Impact factor: 2.822

10.  DNA demethylation enhances myoblasts hypertrophy during the late phase of myogenesis activating the IGF-I pathway.

Authors:  Pamela Senesi; Livio Luzi; Anna Montesano; Ileana Terruzzi
Journal:  Endocrine       Date:  2013-12-24       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.